Finance

Beta
Lists
APVO:NASDAQ
Aptevo Therapeutics Inc
$4.84
+4.54%
(+0.21) 1D
Jun 24, 9:31:19 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for APVO...
Open
$4.84
High
$4.84
Low
$4.84
Mkt. cap
5.93M
Avg. vol.
28.61K
Volume
129.00
52-wk high
$664.20
52-wk low
$3.80
EPS
-$204.04
Beta
1.69
Shares outstanding
1.25M
No. of employees
33
Open
$4.84
High
$4.84
Low
$4.84
Mkt. cap
5.93M
Avg. vol.
28.61K
Volume
129.00
52-wk high
$664.20
52-wk low
$3.80
EPS
-$204.04
Beta
1.69
Shares outstanding
1.25M
No. of employees
33
News stories
From sources across the web
About Aptevo Therapeutics Inc
CEO-
Employees33
Founded2016
HeadquartersSeattle, Washington, United States
SectorBiotechnology
Websiteaptevotherapeutics.com
Analyst Ratings
Based on 1 analyst giving stock ratings to APVO in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for APVO in the last 3 months.
Highest
Current $4.84
$21.00 (+333.88%)
Average
$21.00 (+333.88%)
Lowest
$21.00 (+333.88%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Jonathan Aschoff
Roth MKM
Buy
Maintained
$21.00
+333.9%
05/14/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.33M
4.04M
3.54M
3.92M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.90M
3.57M
2.46M
2.91M
Operating expense
6.23M
7.61M
6.00M
6.84M
Total operating expenses
6.23M
7.61M
6.00M
6.84M
Operating income
-6.23M
-7.61M
-6.00M
-6.84M
Other non operating income
22.00K
61.00K
190.00K
140.00K
EBT including unusual items
-6.20M
-7.55M
-5.81M
-6.70M
EBT excluding unusual items
-6.20M
-7.55M
-5.81M
-6.70M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.20M
-7.55M
-5.81M
-6.70M
Net profit margin
-
-
-
-
Earnings per share
-151.20
-40.14
-
-6.41
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.18M
-7.56M
-5.92M
-6.80M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer